IRIS Institutional Research Information System - OPENBS Open Archive UniBS

ALBINI, Laura
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 928
EU - Europa 641
AS - Asia 143
AF - Africa 3
OC - Oceania 2
Totale 1.717
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 928
DE - Germania 315
CN - Cina 106
UA - Ucraina 90
GB - Regno Unito 87
RU - Federazione Russa 68
FI - Finlandia 32
HK - Hong Kong 24
IT - Italia 17
IE - Irlanda 14
BE - Belgio 7
FR - Francia 6
SG - Singapore 6
IN - India 4
AU - Australia 2
RO - Romania 2
BY - Bielorussia 1
CI - Costa d'Avorio 1
DZ - Algeria 1
ID - Indonesia 1
JP - Giappone 1
NL - Olanda 1
PL - Polonia 1
TN - Tunisia 1
TW - Taiwan 1
Totale 1.717
Salva come PNG Salva come JPEG
Città #
Fairfield 173
Woodbridge 123
Houston 92
Ashburn 67
Seattle 67
Jacksonville 65
Cambridge 50
Wilmington 47
Chandler 42
Ann Arbor 40
Princeton 26
Hong Kong 24
Lancaster 23
Nanjing 23
New York 20
Helsinki 18
Dublin 14
Nanchang 14
Beijing 13
Nürnberg 13
San Diego 10
Brussels 7
Changsha 7
Tianjin 7
Dearborn 6
Des Moines 6
Hebei 5
Shenyang 5
Brescia 4
Jiaxing 4
Ningbo 4
Shanghai 4
Verona 4
Jinan 3
London 3
Milan 3
Taiyuan 3
Boardman 2
Changchun 2
Hangzhou 2
Kunming 2
Lanzhou 2
Orange 2
Taizhou 2
Washington 2
Abidjan 1
Amsterdam 1
Carhaix 1
Chicago 1
Chiswick 1
Cleveland 1
Corinella 1
Guangzhou 1
Lappeenranta 1
Minsk 1
Monmouth Junction 1
New Bedfont 1
Perth 1
Redmond 1
San Mateo 1
Surabaya 1
Taipei 1
Warsaw 1
Totale 1.073
Salva come PNG Salva come JPEG
Nome #
The Disagreement Among Methods to Evaluate Glomerular Filtration Rate in HIV-Infected Patients Naive to Antiretroviral Therapy. 189
Burden of Non-AIDS-Defining and Non-Virus-Related Cancers Among HIV-Infected Patients in the Combined Antiretroviral Therapy Era. 153
The evolving burden of HIV infection compared with other chronic diseases in northern Italy 151
Evaluation of Liver Fibrosis: Concordance Analysis between Noninvasive Scores (APRI and FIB-4) Evolution and Predictors in a Cohort of HIV-Infected Patients without Hepatitis C and B Infection 141
A randomized, pilot trial to evaluate glomerular filtration rate by creatinine or cystatin C in naive HIV-infected patients after tenofovir/emtricitabine in combination with atazanavir/ritonavir or efavirenz 141
Evolution of transmitted HIV-1 drug resistance in HIV-1-infected patients in Italy from 2000 to 2010. 135
Prospective evaluation of bone markers, parathormone and 1,25-(OH)2 vitamin D in HIV-positive patients after the initiation of tenofovir/emtricitabine with atazanavir/ritonavir or efavirenz. 133
Efficacy and safety of a switch to unboosted atazanavir in combination with nucleoside analogues in HIV-1-infected patients with virological suppression under antiretroviral therapy 133
Cryptogenic liver diseases: sailing by sight from HIV co-infection with hepatitis viruses to HIV mono-infection through the Pillars of Hercules. 130
Cancer incidence and mortality for all causes in HIV-infected patients over a quarter century: a multicentre cohort study 129
Contribution of Genetic Background, Traditional Risk Factors, and HIV-Related Factors to Coronary Artery Disease Events in HIV-Positive Persons 118
Impact of detectable human cytomegalovirus DNAemia on viro-immunologicaleffectiveness of HAART in HIV-infected patients naive to antiretroviral therapy 95
Increase in Standard Cholesterol and Large HDL Particle Subclasses in Antiretroviral-Naïve Patients Prescribed Efavirenz Compared to Atazanavir/Ritonavir 90
Reply to van der Pas et al 11
Totale 1.749
Salva come PNG Salva come JPEG
Categoria #
all - tutte 5.870
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.870
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019130 0 0 0 0 0 0 0 0 0 0 70 60
2019/2020515 67 23 27 69 37 55 57 56 48 51 4 21
2020/2021213 4 39 4 21 14 32 7 23 25 19 18 7
2021/2022143 7 41 0 1 2 1 9 5 5 25 9 38
2022/2023129 13 2 0 3 16 36 0 14 29 1 8 7
2023/2024108 6 6 10 17 7 25 8 3 25 1 0 0
Totale 1.749